Analysts See $-0.05 EPS for R1 RCM Inc. (RCM)

October 2, 2018 - By Hugh Holland

Analysts expect R1 RCM Inc. (NASDAQ:RCM) to report $-0.05 EPS on October, 30.They anticipate $0.03 EPS change or 37.50 % from last quarter’s $-0.08 EPS. After having $-0.07 EPS previously, R1 RCM Inc.’s analysts see -28.57 % EPS growth. The stock decreased 4.80% or $0.48 during the last trading session, reaching $9.53. About 423,343 shares traded. R1 RCM Inc. (NASDAQ:RCM) has risen 211.67% since October 2, 2017 and is uptrending. It has outperformed by 196.05% the S&P500.

R1 RCM Inc. provides revenue cycle management and physician advisory services for healthcare providers in the United States. The company has market cap of $1.05 billion. It offers revenue cycle management services to manage their revenue cycles, which encompass patient registration, insurance and benefit verification, medical treatment documentation and coding, and bill preparation and collection from patients and payers. It currently has negative earnings. The firm also provides physician advisory services, which offer concurrent level of care billing classification reviews, as well as retrospective chart audits to assist hospitals in properly billing payers for selected services.

Another recent and important R1 RCM Inc. (NASDAQ:RCM) news was published by Benzinga.com which published an article titled: “Chardan: R1 RCM Will Make A Full Recovery” on September 04, 2018.

R1 RCM Inc. (NASDAQ:RCM) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>